Search

Dr. V. FeinZachary's abstract, " Effect of testosterone therapy on breast density in transmasculine individuals: A pilot study" has been accepted for an electronic presentation at the 2022 SBI/ACR Breast Imaging Symposium. Congratulations! See the presentation here.

Dr Wulf, one of Dr Heng's mentor at BIDMC, has been recognised as a nominee for the 2022 ASCO Women Who Conquer Cancer (WWCC) Mentorship Award. https://www.conquer.org/news/conquer-cancer-announces-2022-wwcc-mentorsh... This is a well-deserved achivement for Dr. Wulf. She is an outstanding female...

Dr. Heng was one of the speakers at the BIDMC Precision RNA Medicine Core Detection Workshop, "Tools for the discovery and validation of clinically important microRNA biomarkers” on Friday, April 29 th at 9:00 AM – 10:30 AM ET. The title of her talk was, " “Plasma miRNAs associated with cisplatin...

Congratulations to Dr Baker. Her abstract, "Comparing the Immunohistochemistry Scoring of Breast Tumor Tissue Microarrays Using Definiens, InForm, and QuPath" has been accepted for Poster presentation at the CAP annual meeting 2022.

Transgender Breast Care Working Group, led by Dr. Heng was nominated for the 2023 Group/Program Diversity Award given by Harvard Medical School. Although HMS is unable to honor each nominee with an award, HMS believes that being nominated is an honor unto itself and hope that the team will continue...

Dr. Heng's team will be presenting 3 abstracts at this upcoming AACR conference: Effect of testosterone therapy on quantitative breast lobular atrophy in transmasculine individuals (Short Talk) Effect of cross-sex testosterone therapy on Pik3ca-driven breast cancer incidence in mice (Poster) Effect...

Congratulations to Dr Baker. Her abstract, "Increased Stem Cell Marker Expression in the Breast is Associated with Decreased Terminal Duct Lobular Unit Involution " has been accepted for Poster presentation at the USCAP annual meeting 2024.

Dr. Heng's abstract, "Male Immune Modulation Reduces the Efficacy of PARP Inhibition in the Treatment of Brca1 mut Breast Tumors" has been accepted for an oral presentation at the upcoming 4th Annual Reproductive Medicine Symposium. Congratulations!

Mirxes US featured two of our projects on their blog: BRCA-related breast cancer miRNA study: https://www.mirxes.us/blog/plasma-mir-362-3p-expression-linked-to-improved-cisplatin-response-in-brca-related-breast-cancer/ Hodgkin's lymphoma-related EBV miRNA study : https://www.mirxes.us/blog/mirxes...